EMA has recommended a permanent marketing authorization in the EU for Pfizer-BioNTech's COVID-19 vaccine. A conditional marketing authorization is currently in effect and must be renewed annually.
EMA has recommended a permanent marketing authorization in the EU for Pfizer-BioNTech's COVID-19 vaccine. A conditional marketing authorization is currently in effect and must be renewed annually. 
ema.europa.eu
English (US) 